German social media is aflame with speculation about the authenticity of what purport to be leaked minutes from a Covid vaccine meeting at the Robert Koch Institute in 2020. Robert Kogon thinks they're forgeries.
Covid vaccine maker BioNTech has returned to making a loss as vaccine sales tank. Yet the company projects a return to pandemic-level sales in the autumn. Does BioNTech know something that we don’t, asks Robert Kogon.
Elon Musk's endorsement of mRNA technology leaves many of his fans perplexed. What they don't appear to realise is Musk is part of the mRNA project and has a direct commercial stake in it.
After a recent study found that mRNA promotes cancer, Robert Kogon asks if Covid vaccine maker BioNTech already knew that in 2019 thanks to the hidden results of one of its failed cancer treatment trials.
BioNTech acquired its vaccine manufacturing plant in Germany in October or November 2020. How did it know at that point that its vaccine was going to be approved, asks Robert Kogon.
The German Government rushed to lock down in 2020 against the scientific advice of its public health authority, documents reveal. Was it swayed by a dream of becoming "vaccine hub Germany", asks Robert Kogon.
Before the pandemic, Covid vaccine company BioNTech was focused on mRNA cancer treatment. But all its trials had failed. Why – did the drugs end up increasing cancers? We don't know because the results are kept secret.
Germany and the EU have funded Covid vaccine-maker BioNTech's expansion into Africa to the tune of £500m. But what vaccines are the new facilities going to be making exactly when BioNTech only has one product?
Klaus Cichutek, the Head of the German medicines regulator – which has a very cosy relationship with vaccine-maker BioNTech – recently declared: "We ARE the European Medicines Agency." Was anyone watching the watchmen?
In a cheery tweet from the opening of the World Health Summit in Berlin, German Minister of Health Karl Lauterbach has declared that it's "only a matter of time until the next pandemic comes".
